1-100 of about 111 matches for site:www.patentsencyclopedia.com bioactive
https://www.patentsencyclopedia.com/app/20220296540
SYNERGISTIC BIOACTIVE COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS - Patent application Inventors list Assignees list Classification tree browser
METHOD FOR PRODUCING A BIOACTIVE COMPONENT-CONTAINING NANO-COMPOSITE, AND A MONTMORILLONITE-BASED, B
https://www.patentsencyclopedia.com/app/20220296525
In this way, bioactive components are drawn towards the nano-clay mineral layers, bioactive components interact with macromolecules
https://www.patentsencyclopedia.com/app/20090270693
Methods and systems for modifying bioactive agent use - Patent application Inventors list Assignees list Classification tree browser
https://www.patentsencyclopedia.com/app/20090271347
Methods and systems for monitoring bioactive agent use - Patent application Inventors list Assignees list Classification tree browser
https://www.patentsencyclopedia.com/app/20090270687
Methods and systems for modifying bioactive agent use - Patent application Inventors list Assignees list Classification tree browser
https://www.patentsencyclopedia.com/app/20090271120
Methods and systems for monitoring bioactive agent use - Patent application Inventors list Assignees list Classification tree browser
https://www.patentsencyclopedia.com/app/20090271215
Methods and systems for detecting a bioactive agent effect - Patent application Inventors list Assignees list
https://www.patentsencyclopedia.com/app/20090267758
Systems and apparatus for measuring a bioactive agent effect - Patent application Inventors list Assignees list
https://www.patentsencyclopedia.com/app/20220296867
an in vivo environment, the drug releasing membrane storing at least one bioactive agent, wherein the
https://www.patentsencyclopedia.com/inventor/elizabeth-a-sweeney-seatt...
07-09-2009 20090267758 Systems and apparatus for measuring a bioactive agent effect - Apparatus and
https://www.patentsencyclopedia.com/hgl/09-22-22/09-22-22_9
described. In some aspects the liposome particles may contain a bioactive agent. In some
https://www.patentsencyclopedia.com/app/20220296519
described. In some aspects the liposome particles may contain a bioactive agent. In some
https://www.patentsencyclopedia.com/app/20090192449
24. A bioactive material administration system comprising:means for implementing a bioactive material selection from within
METHOD OF MANUFACTURING ePTFE ARTIFICIAL VASCULAR GRAFT WITH IMPROVED BLOOD COMPATIBILITY BY SELECTI
https://www.patentsencyclopedia.com/app/20220233300
a bioactive metal target under a predetermined reaction condition. [0022] The bioactive metal used in
https://www.patentsencyclopedia.com/app/20100030089
while the individual is under the influence of a bioactive agent, identifying at least
https://www.patentsencyclopedia.com/app/20090271010
products, and systems are described that include detecting at least one indication of bioactive agent use by an
https://www.patentsencyclopedia.com/app/20090271008
products, and systems are described that include accepting at least one indication of bioactive agent use by an
https://www.patentsencyclopedia.com/app/20090319301
indication of a schedule for administration of a bioactive agent to an
COMPOSITE MATERIAL, IMPLANT COMPRISING THEREOF, USE OF THE COMPOSITE MATERIAL AND METHODS FOR PREPAR
https://www.patentsencyclopedia.com/app/20220296789
regains its own stability, thereafter being absorbed by the body, and (2) "bioactive" i.e., able to
https://www.patentsencyclopedia.com/app/20090270694
the individual, and/or modifying at least one of a bioactive agent or the
https://www.patentsencyclopedia.com/app/20090326443
a future event time intended by an individual, and causing a bioactive material administration to
https://www.patentsencyclopedia.com/app/20220233294
weight % of the bioactive glass is described, suspension of the bioactive glass in a
https://www.patentsencyclopedia.com/app/20090271122
while the individual is under the influence of a bioactive agent, identifying at least
https://www.patentsencyclopedia.com/app/20100041964
the individual, and/or modifying at least one of a bioactive agent or the
https://www.patentsencyclopedia.com/inventor/robert-langer-newton-us-1...
digestive tract - Systems and methods are described for implementing a bioactive material selection from within
https://www.patentsencyclopedia.com/app/20090271219
with an artificial sensory experience and presenting an indication of a bioactive agent at least partly
https://www.patentsencyclopedia.com/app/20220296851
of the catheter and introducing a fluid containing a bioactive material into the
https://www.patentsencyclopedia.com/app/20220280443
month. The transdermal delivery system employs a plurality of varying diameter bioactive glass capsules configured to
https://www.patentsencyclopedia.com/hgl/06-09-22/06-09-22_60
THE SAME AND DISPLAY PANEL 2022-06-09 20220180803 DISPLAY LIGHTING SYSTEMS WITH BIOACTIVE LIGHTING 2022-06-09
https://www.patentsencyclopedia.com/app/20220296817
The medical delivery device of claim 27, wherein said therapeutic comprises at least one bioactive selected from coagulation factors
https://www.patentsencyclopedia.com/app/20220298471
In other embodiments, the hydrogel support medium can further include at least one bioactive agent that is provided
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_6
family Equidae prior to repair. The dental compositions include a bioactive glass and a
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_2
The present invention relates to methods for encapsulating a bioactive agent such as a
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_8
month. The transdermal delivery system employs a plurality of varying diameter bioactive glass capsules configured to
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_26
and L-fuculose, an L-fucose isomerase, derived from a 2022-09-08 20220282238 BIOACTIVE PEPTIDE MOLECULES DISCOVERED BY
https://www.patentsencyclopedia.com/app/20220233298
giant cells on a cell impermeable layer of an implantable device or bioactive entity (e.g., bioactive scaffold
https://www.patentsencyclopedia.com/app/20220233712
that specialized delivery vehicles are usually obligatory as a means of achieving bioactive delivery. This is especially
https://www.patentsencyclopedia.com/hgl/02-17-22/02-17-22_26
on the base material. 2022-02-17 20220049369 ANTIMICROBIAL CHROMIUM ELECTROPLATING - A bioactive coated substrate includes a
https://www.patentsencyclopedia.com/inventor/jordin-t-kare-seattle-us-...
digestive tract - Systems and methods are described for implementing a bioactive material selection from within
https://www.patentsencyclopedia.com/app/20220282222
of claims 10-38, wherein the bio-ink further comprises one or more bioactive agents. 40. The
https://www.patentsencyclopedia.com/asnl/ta
NEUROPATHIC PAIN 89 TAIPEI MEDICAL UNIVERSITY (TMU) 2014-11-27 / 20140348941 - METHOD FOR MANUFACTURING BIOACTIVE GLASS AND BIOACTIVE
https://www.patentsencyclopedia.com/inventor/gravett-6/
US Patent application number Description Published 20110033540 POLYMER FORMULATIONS FOR DELIVERY OF BIOACTIVE AGENTS - Disclosed in
https://www.patentsencyclopedia.com/inventor/robert-g-matheny-norcross...
component derived from a mammalian source and at least a bioactive component selected from the
https://www.patentsencyclopedia.com/app/20130103000
BACKGROUND OF THE INVENTION [0003] Convection enhanced delivery ("CED") of a bioactive agent involves introducing a
https://www.patentsencyclopedia.com/app/20110224607
BACKGROUND OF THE INVENTION [0003] Convection enhanced delivery ("CED") of a bioactive agent involves introducing a
https://www.patentsencyclopedia.com/app/20220233299
therapies in general, cells, viruses, viral vectors, bacteria, proteins, antibodies, and other bioactive entities may be introduced
https://www.patentsencyclopedia.com/app/20220234006
therapies in general, cells, viruses, viral vectors, bacteria, proteins, antibodies, and other bioactive entities may be introduced
https://www.patentsencyclopedia.com/asnl/na
Nanao Intelligent Biomedical Engineering Corporation Co., Ltd. 2013-09-12 / 20130237484 - HUMAN-DERIVED CELL-PERMEABLE PEPTIDE BIOACTIVE PEPTIDE CONJUGATE, AND
https://www.patentsencyclopedia.com/inventor/elizabeth-a-holmes-palo-a...
ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of
HUMAN UMBILICAL CORD-DERIVED COMPOSITIONS AND USES THEREOF FOR TREATING NEUROPATHY - Patent applicat
https://www.patentsencyclopedia.com/app/20220280573
technique is designed to release a rich volume of soluble bioactive components relevant to
https://www.patentsencyclopedia.com/app/20220279814
for the prevention of age-related cognitive decline. Rich in bioactive peptides combined with DHA
https://www.patentsencyclopedia.com/asnl/ag
Device 2 Agency of Science, Technology and Research 2011-03-03 / 20110053783 - BIOACTIVE SURFACE FOR HEPATOCYTE
https://www.patentsencyclopedia.com/app/20090101838
become biologically active or inactive. Grissom et al, "Bioconjugates and delivery of bioactive agents," U.S. Pat. No
https://www.patentsencyclopedia.com/app/20090101846
become biologically active or inactive. Grissom et al, "Bioconjugates and delivery of bioactive agents," U.S. Pat. No
https://www.patentsencyclopedia.com/asnl/la
System Using Communication Network 2 LABBELL INC. 2011-07-21 / 20110177546 - METHOD OF DETECTING BIOACTIVE MOLECULES IN A
https://www.patentsencyclopedia.com/app/20090105561
821, 851 to reduce, postpone, or forego an output of a bioactive material, for example
https://www.patentsencyclopedia.com/app/20090101841
become biologically active or inactive. Grissom et al, "Bioconjugates and delivery of bioactive agents," U.S. Pat. No
https://www.patentsencyclopedia.com/app/20090112048
821, 851 to reduce, postpone, or forego an output of a bioactive material, for example
https://www.patentsencyclopedia.com/app/20090104179
become biologically active or inactive. Grissom et al, "Bioconjugates and delivery of bioactive agents," U.S. Pat. No
https://www.patentsencyclopedia.com/inventor/holmes-ca-3/
ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of
https://www.patentsencyclopedia.com/app/20090104113
become biologically active or inactive. Grissom et al, "Bioconjugates and delivery of bioactive agents," U.S. Pat. No
https://www.patentsencyclopedia.com/asnl/aj
AROMATICS PVT LTD. 2013-02-07 / 20130035380 - PROCESS FOR SELECTIVE EXTRACTION OF BIOACTIVE AND BIOAVAILABLE
https://www.patentsencyclopedia.com/asnl/ap
01-30 / 20140030391 - Atmosphere Control Around Respiring Biological Materials 3 Apipuri, Inc. 2015-04-02 / 20150093494 - Bioactive Additive 1 APIQE 2015
https://www.patentsencyclopedia.com/asnl/am
Foam-Backed Adhesive and Apparatus 1 Ambe Phytoextracts Pvt. Ltd. 2021-11-18 / 20210353590 - BIOACTIVE FORMULATION AND METHOD
https://www.patentsencyclopedia.com/app/20220280425
sodium retention, respectively. [0004] In recent years, the use of bioactive compounds from plant sources
https://www.patentsencyclopedia.com/app/20090105694
821, 851 to reduce, postpone, or forego an output of a bioactive material, for example
https://www.patentsencyclopedia.com/inventor/covidien-lp-mansfield-us-...
of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The
https://www.patentsencyclopedia.com/app/20090104250
821, 851 to reduce, postpone, or forego an output of a bioactive material, for example
https://www.patentsencyclopedia.com/app/20090112189
821, 851 to reduce, postpone, or forego an output of a bioactive material, for example
https://www.patentsencyclopedia.com/asnl/wa
2021-10-21 / 20210322500 - METHOD FOR PRODUCING STABLE ACTINIDIA DELICIOSA POWDER WITH HIGH LEVEL BIOACTIVE ACTINIDIN ENZYME 1 WAITBUSTERS
https://www.patentsencyclopedia.com/app/20090137866
821, 851 to reduce, postpone, or forego an output of a bioactive material, for example
https://www.patentsencyclopedia.com/app/20220282000
homogenous. [0012] Another aspect of the invention relates to a bioactive krill-chitin composition prepared
https://www.patentsencyclopedia.com/app/20220235422
In another embodiment, one or both of the first and second bioactive components may comprise an
https://www.patentsencyclopedia.com/assignee/dexcom-inc/
on the a posteriori calibration distribution information. 09-18-2014 20140275900 BIOINTERFACE MEMBRANES INCORPORATING BIOACTIVE AGENTS - A biointerface
https://www.patentsencyclopedia.com/app/20220238226
living organisms, including primary and secondary metabolites. The ingestion of bioactive natural compounds, such as
https://www.patentsencyclopedia.com/inventor/chan-sg-5/
Hwa Chan, Singapore SG Patent application number Description Published 20150352220 SELF-ASSEMBLING ULTRASHORT PEPTIDES MODIFIED WITH BIOACTIVE AGENTS BY CLICK CHEMISTRY
https://www.patentsencyclopedia.com/inventor/william-f-mckay-memphis-u...
least one stabilizer agent. Optionally, the bone void filler further includes at least one bioactive agent. 09-11-2008
https://www.patentsencyclopedia.com/hgl/08-04-22/08-04-22_12
TOPICAL WOUND THERAPY, USING AMBIENT AIR FOR THE CREATION OF THREE BIOACTIVE GASES THAT INDEPENDENTLY AND
https://www.patentsencyclopedia.com/hgl/09-01-22/09-01-22_2
09-01 20220273015 FORMULATIONS AND USES THEREOF - Nutritional supplements and formulations containing bioactive substances found in
https://www.patentsencyclopedia.com/app/20220296500
whole composition, such composition comprising at least one thermoplastic polymer and one or more bioactive ingredients in a
https://www.patentsencyclopedia.com/app/20220299520
p21-retinoblastoma (RB) and p16-RB tumour suppressor pathways. SNCs produce a bioactive "secretome," referred to
SYSTEMS AND METHODS FOR HIGH-THROUGHPUT SCREENING AND ANALYSIS OF DRUG DELIVERY SYSTEMS IN VITRO - P
https://www.patentsencyclopedia.com/app/20220299494
preparation of aqueous silk fibroin solutions, but also such solutions in conjunction with bioactive agents. [0048] In
https://www.patentsencyclopedia.com/app/20220296522
From the preliminary data, it appears that B12 or B14 can be significantly more bioactive than Bryostatin-1. Since
https://www.patentsencyclopedia.com/hgl/02-17-22/02-17-22_21
Phomoxanthone A - Methods, compositions, and kits are provided for synthesizing bioactive chromane, the method
https://www.patentsencyclopedia.com/app/20220280428
understood to include each whole integer within the range. [0050] As used herein, "bioactive" shall include a
COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASE
https://www.patentsencyclopedia.com/app/20220280475
to several polyphenol compounds and derivatives thereof, related to ellagitannins, as bioactive natural compounds found in
https://www.patentsencyclopedia.com/inventor/dixit-in-5/
server. 02-06-2014 Preety Dixit, Lucknow IN Patent application number Description Published 20140079834 BIOACTIVE FRACTIONS AND COMPOUNDS
https://www.patentsencyclopedia.com/app/20090093807
element may include a biocompatible material, and may include a bioactive component (such as a
Vasculature and lymphatic system imaging and ablation associated with a local bypass - Patent applic
https://www.patentsencyclopedia.com/app/20090093713
element may include a biocompatible material, and may include a bioactive component (such as a
Vasculature and lymphatic system imaging and ablation associated with a reservoir - Patent applicati
https://www.patentsencyclopedia.com/app/20090093728
element may include a biocompatible material, and may include a bioactive component (such as a
ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHO
https://www.patentsencyclopedia.com/app/20220236257
compound comprising a second oligonucleotide (ODN-2) covalently bound to a bioactive moiety, either directly or
https://www.patentsencyclopedia.com/app/20160136411
BACKGROUND OF THE INVENTION [0003] Convection enhanced delivery ("CED") of a bioactive agent involves introducing a
https://www.patentsencyclopedia.com/app/20120323175
BACKGROUND OF THE INVENTION [0003] Convection enhanced delivery ("CED") of a bioactive agent involves introducing a
Electrode for Stimulating Bone Growth, Tissue Healing and/or Pain Control, and Method of Use - Paten
https://www.patentsencyclopedia.com/app/20090054951
20120003188 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived
https://www.patentsencyclopedia.com/inventor/stephen-d-pacetti-san-jos...
The biocompatible polymer or polymer blend described herein and optionally a bioactive agent can form a
https://www.patentsencyclopedia.com/app/20220281937
the biologically active polypeptides comprise cytokines, chemokines, growth factors, protein toxins, immunoglobulin domains, enzymes, or other bioactive proteins. 81. The
https://www.patentsencyclopedia.com/app/20220280448
herein, the term "bioactivity" can be defined as how the nutrient or bioactive compound is transported and
UNIT ORAL DOSE COMPOSITIONS COMPOSED OF IBUPROFEN AND FAMOTIDINE FOR THE TREATMENT OF ACUTE PAIN AND
https://www.patentsencyclopedia.com/app/20220233510
0041] In other aspects, the unit oral dose compositions can include other bioactive agents. In one
https://www.patentsencyclopedia.com/app/20220279833
marianum. [0028] Botanical materials often include compounds from various classes known to provide certain bioactive effects, such as minerals
https://www.patentsencyclopedia.com/app/20220235119
and their ability to bind TCRs. FIG. 10A shows comparison of bioactive/neurotoxin-like (green) and